Have a feature idea you'd love to see implemented? Let us know!

BAX Baxter International Inc

Price (delayed)

$29.5

Market cap

$15.06B

P/E Ratio

140.48

Dividend/share

$1.04

EPS

$0.21

Enterprise value

$26.84B

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
Baxter International's debt has decreased by 22% YoY
The gross profit has grown by 10% year-on-year
The company's equity rose by 3% QoQ but it fell by 2.8% YoY
BAX's P/E is 177% above its last 4 quarters average of 50.8
BAX's net income has dropped by 96% year-on-year and by 96% since the previous quarter

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
510.59M
Market cap
$15.06B
Enterprise value
$26.84B
Valuations
Price to book (P/B)
1.91
Price to sales (P/S)
1.08
EV/EBIT
36.51
EV/EBITDA
14.82
EV/Sales
1.92
Earnings
Revenue
$13.99B
Gross profit
$5.32B
Net income
$108M
EBIT
$735M
EBITDA
$1.81B
Free cash flow
$549M
Per share
EPS
$0.21
EPS diluted
$0.21
Free cash flow per share
$1.08
Book value per share
$15.43
Revenue per share
$27.43
TBVPS
$30.28
Balance sheet
Total assets
$26.68B
Total liabilities
$18.73B
Debt
$13.19B
Equity
$7.87B
Working capital
$2.66B
Liquidity
Debt to equity
1.68
Current ratio
1.43
Quick ratio
0.51
Net debt/EBITDA
6.5
Margins
EBITDA margin
12.9%
Gross margin
38.1%
Net margin
0.8%
Operating margin
3.4%
Efficiency
Return on assets
0.4%
Return on equity
1.3%
Return on invested capital
3.6%
Return on capital employed
3.6%
Return on sales
5.3%
Dividend
Dividend yield
3.53%
DPS
$1.04
Payout ratio
495.2%

BAX stock price

How has the Baxter International stock price performed over time
Intraday
2.08%
1 week
-2.7%
1 month
-9.59%
1 year
-23.58%
YTD
-23.69%
QTD
-22.31%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$13.99B
Gross profit
$5.32B
Operating income
$479M
Net income
$108M
Gross margin
38.1%
Net margin
0.8%
BAX's net income has dropped by 96% year-on-year and by 96% since the previous quarter
Baxter International's net margin has plunged by 96% YoY and by 96% from the previous quarter
The operating margin has decreased by 21% YoY and by 6% from the previous quarter
Baxter International's operating income has decreased by 18% YoY and by 4.8% from the previous quarter

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
P/E
140.48
P/B
1.91
P/S
1.08
EV/EBIT
36.51
EV/EBITDA
14.82
EV/Sales
1.92
BAX's P/E is 177% above its last 4 quarters average of 50.8
The EPS has plunged by 96% YoY and by 96% from the previous quarter
BAX's P/B is 53% below its 5-year quarterly average of 4.1 and 20% below its last 4 quarters average of 2.4
The company's equity rose by 3% QoQ but it fell by 2.8% YoY
BAX's P/S is 58% below its 5-year quarterly average of 2.6 and 23% below its last 4 quarters average of 1.4
The revenue is up by 3.1% year-on-year

Efficiency

How efficient is Baxter International business performance
The company's return on equity has shrunk by 97% YoY and by 96% QoQ
The ROA has plunged by 96% YoY and by 95% from the previous quarter
The ROS has plunged by 77% YoY and by 77% from the previous quarter
The ROIC has plunged by 76% from the previous quarter and by 72% YoY

Dividends

What is BAX's dividend history
DPS
$1.04
Dividend yield
3.53%
Payout ratio
495.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Baxter International financials performed over time
The total assets is 42% more than the total liabilities
The quick ratio has dropped by 62% year-on-year and by 34% since the previous quarter
The current ratio fell by 26% YoY but it rose by 2.1% QoQ
Baxter International's debt is 68% more than its equity
Baxter International's debt has decreased by 22% YoY
The debt to equity has declined by 20% year-on-year and by 4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.